Invention Grant
US09040494B2 RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
有权
RNAi介导的卷曲相关蛋白-1抑制治疗青光眼
- Patent Title: RNAi-mediated inhibition of frizzled related protein-1 for treatment of glaucoma
- Patent Title (中): RNAi介导的卷曲相关蛋白-1抑制治疗青光眼
-
Application No.: US13429913Application Date: 2012-03-26
-
Publication No.: US09040494B2Publication Date: 2015-05-26
- Inventor: Abbot F. Clark , Wan-Heng Wang , Loretta Graves McNatt , Jon E. Chatterton
- Applicant: Abbot F. Clark , Wan-Heng Wang , Loretta Graves McNatt , Jon E. Chatterton
- Applicant Address: CH
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Current Assignee Address: CH
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07H21/02 ; C07H21/04 ; C12N15/113 ; A61K38/00

Abstract:
RNA interference is provided for inhibition of Frizzled Related Protein-1 mRNA expression, in particular, for treating patients having glaucoma or at risk of developing glaucoma.
Public/Granted literature
- US20120178795A1 RNAI-MEDIATED INHIBITION OF FRIZZLED RELATED PROTEIN-1 FOR TREATMENT OF GLAUCOMA Public/Granted day:2012-07-12
Information query